NCT02664116 - IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions

Migraine Headache

Interventions

DRUG

Diclofenac postassium powder for oral solution and placebo injection

Diclofenac postassium powder for oral solution 50 mg in 1 ounce water orally, single dose and placebo normal saline 2ml intramuscular injection, single dose

DRUG

Ketorolac intramuscular injection and placebo oral solution

ketorolac 60 mg in 2 ml intramuscular injection, single dose and placebo oral solution, 1 ounce, single dose

Trial Locations (1)

92037

RECRUITING

Scripps Clinic, La Jolla